Vetoquinol SA (0O1O.L)

EUR 77.4

(-0.39%)

Gross Profit Summary of Vetoquinol SA

  • Vetoquinol SA's latest annual gross profit in 2023 was 291.37 Million EUR , up 116.21% from previous year.
  • Vetoquinol SA's latest quarterly gross profit in 2024 Q2 was 131.15 Million EUR , down 0.0% from previous quarter.
  • Vetoquinol SA reported a annual gross profit of 172.36 Million EUR in annual gross profit 2022, up 2.98% from previous year.
  • Vetoquinol SA reported a annual gross profit of 167.37 Million EUR in annual gross profit 2021, up 35.0% from previous year.
  • Vetoquinol SA reported a quarterly gross profit of 39.21 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Vetoquinol SA reported a quarterly gross profit of 156.28 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Gross Profit of Vetoquinol SA (2023 - 2005)

Year Gross Profit Gross Profit Growth
2023 291.37 Million EUR 116.21%
2022 172.36 Million EUR 2.98%
2021 167.37 Million EUR 35.0%
2020 123.97 Million EUR -39.78%
2019 205.88 Million EUR 5.03%
2018 196.03 Million EUR 4.99%
2017 186.71 Million EUR 3.69%
2016 180.06 Million EUR 3.72%
2015 173.61 Million EUR 8.2%
2014 160.45 Million EUR 7.14%
2013 149.77 Million EUR -19.52%
2012 186.1 Million EUR 54.72%
2011 120.28 Million EUR -2.35%
2010 123.17 Million EUR -27.92%
2009 170.89 Million EUR 8.06%
2008 158.14 Million EUR 52.78%
2007 103.51 Million EUR -25.36%
2006 138.68 Million EUR 8.46%
2005 127.86 Million EUR 0.0%

Peer Gross Profit Comparison of Vetoquinol SA

Name Gross Profit Gross Profit Difference
Boiron SA 358.08 Million EUR 18.628%
Laboratorios Farmaceuticos Rovi, S.A. 483.34 Million EUR 39.716%
Valneva SE 52.83 Million EUR -451.47%
AB Science S.A. 587 Thousand EUR -49538.841%
Nanobiotix S.A. 42.35 Million EUR -587.898%
PHAXIAM Therapeutics S.A. 1.32 Million EUR -21874.359%
Vivoryon Therapeutics N.V. -3.09 Million EUR 9514.54%
BioSenic S.A. 543 Thousand EUR -53561.142%
ABIVAX Société Anonyme 3.91 Million EUR -7344.558%
Formycon AG 23.3 Million EUR -1150.29%